Changes
/* Global Acne Medications Market */
[[Image:BCC ACNE.jpg|center|]]thumb|center|632px * 341px|Source: BCC Research,[http://www.marketresearch.com/BCC-Research-v374/Skin-Disease-Treatment-Technologies-Global-7616658/ BCC Research]]]
{|border="0" cellspacing="0" cellpadding = "0" width="100%"
|align = "center"|<font color="#282828"><font size = "4">'''The Acne Product Pipeline'''</font></font>
[[Image:USACNE2012.jpg|center]] |thumb|center|632px * 341px|Source: IBIS World,[http://www.ibisworld.com/industry/acne-treatment-manufacturing-otc.html IBIS World]]]
===Industry Forecast===
* From 2012 to 2017, industry revenue is expected to go up an annualized rate of 3.1% to $2.7 billion from current level of $2.3 billion.
* Improving economic conditions is likely to drive the market, as greater disposable income growth allows consumers to spend on higher-priced over-the-counter (OTC) items.
[[Image:US2018 acne.jpg|center|thumb|center|632px * 341px|Source:IBIS World,[http://www.ibisworld.com/industry/acne-treatment-manufacturing-otc.html]]]
